These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24559545)

  • 1. Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: a phenomenological hermeneutic study.
    Hansen C; Konradsen H; Abrahamsen B; Pedersen BD
    Int J Qual Stud Health Well-being; 2014; 9():22438. PubMed ID: 24559545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's lived experiences of learning to live with osteoporosis: a longitudinal qualitative study.
    Hansen CA; Abrahamsen B; Konradsen H; Pedersen BD
    BMC Womens Health; 2017 Mar; 17(1):17. PubMed ID: 28279157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study.
    Mazor KM; Velten S; Andrade SE; Yood RA
    Drugs Aging; 2010 Dec; 27(12):999-1008. PubMed ID: 21087069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
    Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
    Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left in limbo - Experiences and needs among postmenopausal women newly diagnosed with osteoporosis without preceding osteoporotic fractures: A qualitative study.
    Jakobsen PR; Hermann AP; Søndergaard J; Wiil UK; Dixon RF; Clemensen J
    Post Reprod Health; 2018 Mar; 24(1):26-33. PubMed ID: 29392982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Rothmann MJ; Möller S; Holmberg T; Højberg M; Gram J; Bech M; Brixen K; Hermann AP; Glüer CC; Barkmann R; Rubin KH
    Osteoporos Int; 2017 Dec; 28(12):3389-3399. PubMed ID: 28875257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
    Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The invisible disease: making sense of an osteoporosis diagnosis in older age.
    Weston JM; Norris EV; Clark EM
    Qual Health Res; 2011 Dec; 21(12):1692-704. PubMed ID: 21810994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Men's experiences of having osteoporosis vertebral fractures: a qualitative study using interpretative phenomenological analyses.
    Minns Lowe CJ; Toye F; Barker KL
    Osteoporos Int; 2019 Jul; 30(7):1403-1412. PubMed ID: 31041474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M; Moriwaki K; Noto S; Takiguchi T
    Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.
    Lukert B; Satram-Hoang S; Wade S; Anthony M; Gao G; Downs R
    Drugs Aging; 2011 Sep; 28(9):713-27. PubMed ID: 21913737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
    Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S; John B; Mohan S; Paul TV
    Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views.
    Alami S; Hervouet L; Poiraudeau S; Briot K; Roux C
    PLoS One; 2016; 11(6):e0158365. PubMed ID: 27355576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Bansal S; Pecina JL; Merry SP; Kennel KA; Maxson J; Quigg S; Thacher TD
    Osteoporos Int; 2015 Apr; 26(4):1429-33. PubMed ID: 25614141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted assessment of fracture risk in women at midlife.
    Davis SR; Tan A; Bell RJ
    Osteoporos Int; 2015 Jun; 26(6):1705-12. PubMed ID: 25630574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.